ENWEIDA:Envafolimab Injection
ENWEIDA:Envafolimab Injection
  • Seen : 117 View

0
ENWEIDA:Envafolimab Injection

For adult patients with advanced solid tumors who have unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair gene-deficient (dMMR), including those patients with advanced colorectal cancer who have experienced disease progression after being treated with fluorouracil, oxaliplatin and irinotecan previously, as well as other patients with advanced solid tumors who have experienced disease progression after previous treatment and no satisfactory treatment alternatives.

 

Saler Company Information

Company : Jiangsu Simcere Pharmaceutical Co., Ltd
Phone : 00862585566666
More Information : View
Online order registration form
No comments have been posted yet
loading
Your comment has been sent
ENWEIDA:Envafolimab Injection

For adult patients with advanced solid tumors who have unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair gene-deficient (dMMR), including those patients with advanced colorectal cancer who have experienced disease progression after being treated with fluorouracil, oxaliplatin and irinotecan previously, as well as other patients with advanced solid tumors who have experienced disease progression after previous treatment and no satisfactory treatment alternatives.

 

Saler Company Information

Company : Jiangsu Simcere Pharmaceutical Co., Ltd
Phone : 00862585566666
More Information : View
Online order registration form